These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 8940995)
21. Steroid and peptide hormones and growth factors. Howell A; Wakeling AE Cancer Chemother Biol Response Modif; 1988; 10():117-28. PubMed ID: 3079380 [No Abstract] [Full Text] [Related]
22. Adjuvant therapy for breast cancer. NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506 [TBL] [Abstract][Full Text] [Related]
23. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
24. Secondary hormonal therapy. Smith DC Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134 [TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers. Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524 [TBL] [Abstract][Full Text] [Related]
26. [New developments in the hormonal treatment of breast cancer in postmenopausal women]. Trunet P; Marty M Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232 [TBL] [Abstract][Full Text] [Related]
27. Regarding: Valero V, Buzdar AU, Hortobagyi GN. "Locally Advanced Breast Cancer," The Oncologist 1996;1:8-17. Oliver RT Oncologist; 1996; 1(4):278-279. PubMed ID: 10388003 [TBL] [Abstract][Full Text] [Related]
28. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Li D; Williams JI; Pietras RJ Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639 [TBL] [Abstract][Full Text] [Related]
29. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Schally AV; Varga JL; Engel JB Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344 [TBL] [Abstract][Full Text] [Related]
30. Chemoprevention of colorectal cancer. Das D; Arber N; Jankowski JA Digestion; 2007; 76(1):51-67. PubMed ID: 17947819 [TBL] [Abstract][Full Text] [Related]
31. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related]
32. Effects of the intake of selected vitamins and minerals on cancer prevention. Birt DF Magnesium; 1989; 8(1):17-30. PubMed ID: 2661927 [TBL] [Abstract][Full Text] [Related]
33. Steroid and peptide hormones and growth factors. Howell A; Wakeling AE Cancer Chemother Biol Response Modif; 1987; 9():121-33. PubMed ID: 3079400 [No Abstract] [Full Text] [Related]
35. Receptor-mediated tumor targeting based on peptide hormones. Mezo G; Manea M Expert Opin Drug Deliv; 2010 Jan; 7(1):79-96. PubMed ID: 19947889 [TBL] [Abstract][Full Text] [Related]
36. Tocotrienol as a potential anticancer agent. Ling MT; Luk SU; Al-Ejeh F; Khanna KK Carcinogenesis; 2012 Feb; 33(2):233-9. PubMed ID: 22095072 [TBL] [Abstract][Full Text] [Related]
37. [Hormones and cytostatic drugs in cancer chemotherapy]. Matthias M Z Gesamte Inn Med; 1978 Jul; 33(14):459-65. PubMed ID: 211742 [TBL] [Abstract][Full Text] [Related]
38. [Hormone dependence of colorectal carcinomas]. Lamberts R Z Gastroenterol; 1994 Oct; 32(10):592-6. PubMed ID: 7716996 [TBL] [Abstract][Full Text] [Related]
39. Vitamin-regulated cytokines and growth factors in the CNS and elsewhere. Scalabrino G J Neurochem; 2009 Dec; 111(6):1309-26. PubMed ID: 19799709 [TBL] [Abstract][Full Text] [Related]
40. Natural products for chemopreventive and adjunctive therapy in oncologic disease. Dennis T; Fanous M; Mousa S Nutr Cancer; 2009; 61(5):587-97. PubMed ID: 19838932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]